InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Nicholson Nur, Chief Technical Officer. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Aggregated, 6 disclosures have been recorded. The latest transaction was disclosed on 28 January 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
116,338 shares
Common Stock
SEC:0001193125-26-224604·
116,338 shares
Common Stock
SEC:0001193125-26-224604:0·
€22,502650 shares@ €34.61910.0004% mcap100.0% of flow
Common Stock
SEC:0001127602-22-002812·
€22,502650 shares@ €34.61910.0004% mcap50.0% of flow
Common Stock
SEC:0001127602-22-002812:0·
026,051 shares0
Common Stock
SEC:0001127602-22-002062:0·
026,051 shares0
Common Stock
SEC:0001127602-22-002062·
6 of 6 declarations
About Nicholson Nur
Nicholson Nur is the Chief Technical Officer of Apellis Pharmaceuticals, Inc.
